TXMD compared with HRTX: revenue, margins and what each company keeps, and the suppliers and customers both name

TXMDTherapeuticsMD, Inc.

Mkt capRevenueRevenue

HRTXHeron Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

TXMDTherapeuticsMD, Inc.

HRTXHeron Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TXMD1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±18.3%▲+0.48%×0.03

HRTX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±62.0%▼−31.74%×0.51

May 11 '26±32.7%▼−21.05%×0.65

= impliedTXMD realized, solidHRTX realized, hatchedOne scale, both sides: full bar = 63%× = |realized| ÷ impliedSource: market data

Q1 FY26

±34.8%

▲+11.11%

×0.32

Q3 FY25±24.3%▼−3.39%×0.14

TXMDTherapeuticsMD, Inc.

1.66▼−2.92%· post 1.66

Mkt cap$20.3MRevenue$869,000Q2 FY26Revenue$3MFY25

HRTXHeron Therapeutics, Inc.

0.29▲+4.32%· post 0.29

ClosedNov 6 '26

Mkt cap$55.6MRevenue$38MQ2 FY26Revenue$155MFY25

Compare

ClosedNov 6 '26

TXMDTherapeuticsMD, Inc.

HRTXHeron Therapeutics, Inc.

1.66▼−2.92%post 1.66

Price

0.29▲+4.32%post 0.29

$20.3M

Mkt cap

$55.6M

Q2 FY26$869,000

Revenue

$38MQ2 FY26

FY25$3M

Revenue

$155MFY25

TXMD1.66▼−2.92%vsHRTX0.29▲+4.32%ClosedNov 6 '26